Eight-hundred and thirty-six patients were randomised to therapy at 25 sites in the United States and received at least one dose of loratadine (n = 357), fexofenadine (n = 360) or placebo (n = 119).
The results of this randomised, double-blind, double-dummy, placebo-controlled, parallel-group study demonstrate the efficacy of loratadine and fexofenadine in relieving the common symptoms of SAR, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback